The PennZone

  • Home
  • Non-profit
  • Music
  • Books
  • Entertainment
  • Marketing
  • Legal
  • Health
  • Technology

Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
The PennZone/10291181

Trending...
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Curtis Salgado shares a love letter to the city of Chicago and Otis Rush with new single
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
ECT and Antidepressants: Hidden Dangers
A new study reveals widespread misinformation about electroshock therapy among patients. CCHR says parents are similarly misled about ECT use on teens and children as young as five. Moreover, antidepressants—often a precursor to ECT recommendations—also carry significant risks.

LOS ANGELES - PennZone -- A new study reveals that patients feel misinformed about the risks of electroconvulsive therapy (ECT), reinforcing the argument that the practice should be banned, according to mental health industry watchdog, Citizens Commission on Human Rights International. Study participants shared accounts of immediate cognitive and memory impairments, as well as long-term effects such as profound loss of abilities, memory, humanity, and personal connections, along with psychological harm and a sense of brain damage. Published in Qualitative Health Research, the study highlights that many patients are denied recognition of their adverse outcomes, which intensifies their struggles.[1]

CCHR says that in the U.S., young teens and children under six have undergone ECT. Lacking the ability to consent, parents—often misinformed about its safety and efficacy—agree to the practice. They are likely unaware that no clinical trials have substantiated safety and efficacy.

The information leaflets provided to patients regarding ECT have been found to minimize the prevalence or severity of memory loss, researchers found. The study says, "Following ECT, there is a possibility of permanent adverse effects including memory and cognitive impairment" and that "Iatrogenic harm, the infliction of harm through medical interventions, is a known possible outcome of ECT."

While the survey of consumers occurred in the United Kingdom, CCHR says that similar patient complaints about ECT have been reported to the group in the U.S. and other countries. Recently, CCHR International supported groups helping a Minnesota man who was threatened with court-ordered ECT when he refused to consent to it. The man had already received 17 courses of involuntary shock and was terrified of undergoing more.

More on The PennZone
  • HW Foundation Opens Nominations for Inaugural 50 Under 50 in AI; Deadline Oct. 16
  • Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
  • BJJ App mmaGPT Expands Academy Program to Support Jiu-Jitsu Instructors with AI Technique Coaching
  • Ten Ten Ten Announces Maximizing Clinical Operations

In its letter to the psychiatric hospital attempting to force ECT upon the 44-year-old man, CCHR cited numerous United Nations reports that say involuntary, forced electroshock constitutes torture and that U.S. courts have acknowledged ECT's risks to patients, including brain damage, memory loss, and cognitive disability.[2]

ECT is often recommended when other treatments have not worked, especially antidepressants. These drugs also have iatrogenic side effects. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is currently reviewing safety alerts for 30 antidepressants, after Thomas Kingston, husband of Lady Gabriella Kingston, daughter of Prince and Princess Michael of Kent, fatally shot himself due to adverse effects from these drugs.[3] A coroner ruled Mr. Kingston shot himself due to the adverse effect of the medications he had been prescribed, which included the common antidepressant citalopram. According to evidence given at his inquest, Mr. Kingston had complained that another antidepressant was making him anxious. A medical expert at the inquest, Dr David Healy, suggested this was a sign that SSRI antidepressants "did not suit him" and that he should not have been prescribed citalopram following this. "We need a much more explicit statement saying that these drugs can cause people to commit suicide who wouldn't have otherwise," he said.[4]

MHRA data shows 71 alerts since 2014 over deaths linked to citalopram and 114 for sertraline.[5]

According to JAMA Psychiatry, ECT is recommended after two antidepressants have failed as "first-line" treatments. CCHR says consumers are often misinformed and, therefore, are unaware that treatment side effects can drive them to have suicidal feelings. When these increase, they are further misled into believing it is their mental state "at fault," rather than the adverse mental and physical effects synonymous with both antidepressants and electroshock.

More on The PennZone
  • Turnstone Creative Welcomes Giovanni Amodei as Manager of Strategic Growth
  • CardsNearby Launches Free Nationwide Directory of Card Shows and Local Card Shops for Collectors
  • American Garden Rose Selections™ Announces 2027 Winners
  • Crossroads4Hope Launches Blood Cancer Resource Hub
  • Wilson Venture Capital to Launch News Organization; Will Name Trevor Wilson CEO

During the holiday season, CCHR is committed to raising awareness about individuals experiencing sorrow because of a lost one, loneliness, being away from family, and more. People can become unwitting candidates for having such emotions misdiagnosed as "holiday depression," and put at risk of being prescribed antidepressants. CCHR wants to see different, non-invasive approaches taken to help individuals and strongly urges against agreeing to electroshock therapy, recommending legal support if necessary to prevent it from being forced on any individual.

Founded 55 years ago by the Church of Scientology and psychiatrist Dr. Thomas Szasz, CCHR has achieved significant milestones in mental health reform. In 1976, it played a pivotal role in securing the first-ever prohibition on electroshocking minors in California. Similarly, in 2014, CCHR helped enact legislation in Western Australia that made administering ECT to minors a criminal offense. The organization was also instrumental in prompting the Food and Drug Administration to hold hearings on the potential suicidal effects of SSRI antidepressants, leading to the FDA issuing warnings of suicidal ideation for individuals under 24.
Sources:

[1] Emily Shipwright, David Murphy, "Long-Term Adverse Effects After Electroconvulsive Therapy (ECT): A Narrative Analysis Exploring People's Experiences, Meaning-Making, and Coping," Qualitative Health Research, 2024, journals.sagepub.com/doi/10.1177/10497323241303391

[2] "CCHR Supports Minnesota Man's Opposition to Enforced Electroshock Treatment," CCHR International, 4 Dec. 2024, www.cchrint.org/2024/12/04/cchr-supports-opposition-to-enforced-electroshock-treatment/

[3] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[4] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[5] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Dave's Auto Services Launches Free Seven-Week Fall Maintenance Series for Boyertown-Area Drivers
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • From Newcomers to Neighbors: LINC Celebrates the People Who Make the Valley Home
  • Lehigh Valley's Kellyn Featured in National Film Series Exploring the Future of Diabetes Care
  • Top 100 Golf Coach Daniel Guest and Imagen Golf Announce Partnership with Remo Golf at Fairways Golf Club
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Exonerated Movers Launches in Philadelphia on International Wrongful Conviction Day
  • Atlas Advisors President and Founder Mike McGuire Named a 2026 Leader in Business and Finance by LVB
  • Client 1st Financial Founder Michael Fischer Recognized for Building a Relationship-Rooted Career
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Curtis Salgado shares a love letter to the city of Chicago and Otis Rush with new single
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
  • UVIFY Brings Advanced Autonomous Systems Research to IROS 2026 in Pittsburgh
  • Mad Darbarian is available for views as a Horror Host
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option

Popular on PennZone

  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Lake Norman Philharmonic - Free Community Concert
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • A New Tale Band Makes 9/11 Tribute Song "The Twins" Free for Ceremonies and School Programs
  • New Bethany's 35th Annual Souper Day to Spotlight Connection Between Health, Hunger and Housing
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • Regcrest LLC Publishes Free 50-State Tax Account Closure Checklist Tool
  • The Culture and Travel Report Enters a New Chapter as Travel and Hospitality Brands Take Notice

Similar on PennZone

  • Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
  • Ten Ten Ten Announces Maximizing Clinical Operations
  • American Garden Rose Selections™ Announces 2027 Winners
  • Crossroads4Hope Launches Blood Cancer Resource Hub
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us